Laurence Picon

3.3k total citations
43 papers, 1.5k citations indexed

About

Laurence Picon is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Laurence Picon has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 17 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in Laurence Picon's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (9 papers). Laurence Picon is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (9 papers). Laurence Picon collaborates with scholars based in France, Belgium and United Kingdom. Laurence Picon's co-authors include Gilles Paintaud, David Laharie, M Veyrac, Jean–Frédéric Colombel, Jean‐Louis Dupas, Marc Lémann, Jean–Yves Mary, David Ternant, Raymond Jian and Édouard Louis and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Laurence Picon

42 papers receiving 1.4k citations

Peers

Laurence Picon

GENET

EPIDE

SURGE

IMMUN

GASTR

Yoav Mazor Israel

Mark R. Fleisher United States

Kathleen G. Lomax United States

Jean–Claude Soulé France

Antoine Blain France

Olle Bernell Sweden

Gendre Jp France

Spyros I. Siakavellas Greece

Anna Ramírez‐Morros Spain

J van der Woude Netherlands

Yoav Mazor Israel

Laurence Picon

610 ×0.6

GENET

521 ×0.7

EPIDE

259 ×0.6

SURGE

300 ×0.9

IMMUN

144 ×0.5

GASTR

Citations per year, relative to Laurence Picon Laurence Picon (= 1×) peers Yoav Mazor

Countries citing papers authored by Laurence Picon

Since Specialization

Citations

This map shows the geographic impact of Laurence Picon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Picon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Picon more than expected).

Fields of papers citing papers by Laurence Picon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Picon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Picon. The network helps show where Laurence Picon may publish in the future.

Co-authorship network of co-authors of Laurence Picon

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Picon. A scholar is included among the top collaborators of Laurence Picon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Picon. Laurence Picon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laharie, David, Laurence Picon, D. Gargot, et al.. (2022). How are patients’ preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn’s disease patients. Scandinavian Journal of Gastroenterology. 57(11). 1312–1320. 3 indexed citations

Uzzan, Mathieu, David Laharie, Carmen Stefănescu, et al.. (2021). Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort. Alimentary Pharmacology & Therapeutics. 54(3). 312–319. 36 indexed citations

Ternant, David, Marc Pfister, Denis Mulleman, et al.. (2021). Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model. Clinical Pharmacokinetics. 61(1). 143–154. 7 indexed citations

Laharie, David, Geert D’Haens, Maria Nachury, et al.. (2021). Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial. Clinical Gastroenterology and Hepatology. 20(9). 2074–2082. 15 indexed citations

Boschetti, Gilles, Alexandre Aubourg, Morgane Caulet, et al.. (2019). Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn’s disease: a pilot study. Gastrointestinal Endoscopy. 90(1). 151–157. 10 indexed citations

Ternant, David, Christophe Passot, Alexandre Aubourg, et al.. (2017). Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration. Clinical Pharmacokinetics. 57(9). 1173–1184. 15 indexed citations

Ternant, David, Laurence Picon, Valérie Gouilleux‐Gruart, et al.. (2014). Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease. Clinical Pharmacokinetics. 54(5). 551–562. 52 indexed citations

Louis, Édouard, Jean–Yves Mary, Gwénola Vernier-Massouille, et al.. (2011). Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped. Gastroenterology. 142(1). 63–70.e5. 429 indexed citations

Negreanu, Lucian, et al.. (2008). Pandysautonomie aiguë lentement régressive associée à une achalasie de l’œsophage : à propos d’un cas. Gastroentérologie Clinique et Biologique. 32(1). 46–50. 1 indexed citations

10.

Ternant, David, Alexandre Aubourg, Charlotte Magdelaine–Beuzelin, et al.. (2008). Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients. Therapeutic Drug Monitoring. 30(4). 523–529. 151 indexed citations

11.

d’Altéroche, Louis, et al.. (2008). Évolution à long terme d’une achalasie du sphincter inférieur de l’œsophage et d’une pseudo-obstruction intestinale paranéoplasiques révélatrices d’un carcinome pulmonaire à petites cellules. Gastroentérologie Clinique et Biologique. 32(1). 56–58. 4 indexed citations

12.

Lémann, Marc, Jean–Yves Mary, Bernard Duclos, et al.. (2006). Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial. Gastroenterology. 130(4). 1054–1061. 287 indexed citations

13.

Scott, S. Mark, Charles H. Knowles, Duolao Wang, et al.. (2006). The nocturnal jejunal migrating motor complex: defining normal ranges by study of 51 healthy adult volunteers and meta‐analysis. Neurogastroenterology & Motility. 18(10). 927–935. 25 indexed citations

14.

Bourlier, Pascal, B. Scotto, Véronique Eder, et al.. (2001). The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nuclear Medicine Communications. 22(12). 1295–1304. 9 indexed citations

15.

Picon, Laurence & Stanislas Bruley des Varannes. (2000). [Guidelines for esophageal pH-monitoring in adults].. PubMed. 24(10). 931–43. 7 indexed citations

16.

Metman, Étienne-Henry, et al.. (1999). Risk Factors for Immediate Complications After Progressive Pneumatic Dilation for Achalasia. The American Journal of Gastroenterology. 94(5). 1179–1185. 69 indexed citations

17.

Picon, Laurence, et al.. (1997). [Acute reversible pan-dysautonomia: effect of erythromycin on gastrointestinal involvement].. PubMed. 21(4). 331–4. 1 indexed citations

18.

Lémann, M, Bernard Flourié, Laurence Picon, et al.. (1995). Motor activity recorded in the unprepared colon of healthy humans.. Gut. 37(5). 649–653. 50 indexed citations

19.

Furet, Y, et al.. (1989). Un cas de diarrhée prolongée au Cyclo 3 fort.. La Presse Médicale. 18(29). 1439–1439. 1 indexed citations

20.

Picon, Laurence, et al.. (1988). Pleuro-péricardite toxoplasmique associée à une maladie de Hodgkin. La Revue de Médecine Interne. 9(5). 473–476. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact